Medicinal product of ATC group L04AG08 with the active ingredient OKRELIZUMAB Medicinal product of ATC group L04AG08 with the active ingredient OKRELIZUMAB
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
Medicinal product of ATC group L04AG08 with the active ingredient OKRELIZUMAB Medicinal product of ATC group L04AG08 with the active ingredient OKRELIZUMAB
The subject of the performance of the public contract is the provision of continuous supplies of medicinal products of the ATC group L04AG08 with the active substance Okrelizumab, for a period of 4 years.
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare and Medicine, Chemicals